Women with incontinence who require surgical intervention following a complication from midurethral mesh sling procedure are at significantly increased risk for depression and self-harm compared with ...

Donna Cisson already had lost some control of her bladder. But when her problems began interfering with her sex life, she turned to a specialist who diagnosed her with pelvic organ prolapse—a ...

October 21, 2008 — Clinicians should receive specialized training for the transvaginal placement of mesh products and be vigilant for adverse events, the US Food and Drug Administration (FDA) warned ...

(Reuters) - A Delaware jury on Thursday ordered Boston Scientific to pay $100 million to a woman who said she was injured by transvaginal mesh, a device that is the subject of more than 25,000 ...

The U.S. Food and Drug Administration today issued two final orders to manufacturers and the public to strengthen the data requirements for surgical mesh to repair pelvic organ prolapse (POP) ...

(Reuters) - A Michigan medical funder was ordered to pay about $1.3 million on Monday for his role in a scheme to convince women to have unnecessary surgery to remove their transvaginal mesh implants ...

Transvaginally placed surgical mesh may pose greater safety risks for women with pelvic organ prolapse (POP) undergoing reconstructive surgery than other surgical options — without evidence of greater ...

There is a long history of confusion and controversy regarding the use of polypropylene mesh materials for pelvic floor disorders in women, such as stress urinary incontinence (SUI) or pelvic organ ...

The U.S. Food and Drug Administration has issued an update on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse (POP), indicating these ...

Manufacturers of surgical mesh products must stop selling and distributing their products in the United States immediately, the US Food and Drug Administration ordered Tuesday. The FDA said it "has ...